Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Image 5_EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway.tif by Xiaoying Huang (328697)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

140 H/D Isotopomers Identified by Long-Range NMR Hyperfine Shifts in Ruthenium(III) Ammine Complexes. Hyperconjugation in Ru–NH₃ Bonding by W. Michael Laidlaw (1947022)

“…A single deuteration in an axial ammine increases the tetragonal field parameter (ν) by +2.8 cm^–1, resulting in a HS of −37 ppb in the Cp proton resonance, whereas a single deuteration in an equatorial ammine decreases the field by −1.5 cm^–1 with a HS of +20 ppb, despite a nominal separation of seven chemical bonds. …”

Identification of selected molecules of plant origin able to decrease adiposity <i>in vivo</i>. by Esmail Lutfi (848005)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

<i>Kpna1</i> KO mice show significant impairment in short-term recognition memory and avoidance learning and/or memory. by Koki Sakurai (11690201)

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

“…At very long prices, as the price is increased further (eg. from 30 s to 50 s), the mode of the leisure duration distribution does not change by much although the mean does. …”

Dynasore decreases the production of cholesterol esters from LDL- or AcLDL-derived cholesterol. by Emmanuelle Girard (337171)

3D reconstruction of a control PFC PV interneuron using Neurolucida showing the soma in light blue, the dendrites in green, and the axon in light blue. by Sara Hijazi (21656615)

Statistical parametric mapping (<i>t</i>) intensity projection maps showing areas of significant decreases of grey matter volume (color code, yellow to orange) in a cohort of people with multiple sclerosis compared to healthy control subjects at baseline rendered on to a stereotactically normalized MRI scan in MNI space (z = -26 and -5; x = 46). by Rainer Ehling (89553)

Changes of the plasma ET-1 ( pg/mL) concentrations during the oxygen treatment days in the different dignostic newborns tended to decrease by Derya Benzer (43082)

Image_1_Gut Bacterial Metabolite Urolithin A (UA) Mitigates Ca2+ Entry in T Cells by Regulating miR-10a-5p.pdf by Shaqiu Zhang (4392235)

“…Overexpression of miR-10a-5p significantly decreased STIM1/2 and Orai1 mRNA and protein levels as well as SOCE in CD4⁺ T cells. …”